These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15674874

  • 1. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
    Patel M, Lee CK.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD001093. PubMed ID: 15674874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
    Conterno LO, Silva Filho CR, Rüggeberg JU, Heath PT.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD001834. PubMed ID: 16855979
    [Abstract] [Full Text] [Related]

  • 5. WITHDRAWN: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
    Conterno LO, da Silva Filho CR, Ruggeberg JU, Heath PT.
    Cochrane Database Syst Rev; 2011 Jul 06; 2011(7):CD001834. PubMed ID: 21735387
    [Abstract] [Full Text] [Related]

  • 6. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
    Prasad K, Karlupia N.
    Respir Med; 2007 Oct 06; 101(10):2037-43. PubMed ID: 17706408
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP, Struchiner CJ, Halloran ME.
    Int J Epidemiol; 1995 Oct 06; 24(5):1050-7. PubMed ID: 8557439
    [Abstract] [Full Text] [Related]

  • 8. Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials.
    White M, Idoko O, Sow S, Diallo A, Kampmann B, Borrow R, Trotter C.
    Lancet Infect Dis; 2019 Mar 06; 19(3):327-336. PubMed ID: 30745277
    [Abstract] [Full Text] [Related]

  • 9. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL, Wu X, Li MQ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec 06; 50(12):1079-1083. PubMed ID: 28057112
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
    Khalil M, Al-Mazrou Y, Findlow H, Chadha H, Bosch Castells V, Oster P, Borrow R.
    Vaccine; 2014 Sep 29; 32(43):5715-21. PubMed ID: 25151042
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis.
    Flacco ME, Manzoli L, Rosso A, Marzuillo C, Bergamini M, Stefanati A, Cultrera R, Villari P, Ricciardi W, Ioannidis JPA, Contopoulos-Ioannidis DG.
    Lancet Infect Dis; 2018 Apr 29; 18(4):461-472. PubMed ID: 29371070
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
    LaForce FM, Djingarey M, Viviani S, Preziosi MP.
    Hum Vaccin Immunother; 2018 May 04; 14(5):1098-1102. PubMed ID: 28968148
    [Abstract] [Full Text] [Related]

  • 15. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
    Deeks ED.
    Paediatr Drugs; 2012 Feb 01; 14(1):63-5. PubMed ID: 22149552
    [No Abstract] [Full Text] [Related]

  • 16. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
    Dakar discussion group on priorities for research on epidemic meningococcal disease in AfricaFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel St., London WC1E 7HT, UK. brian.greenwood@lshtm.ac.uk, Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G.
    Vaccine; 2013 Mar 01; 31(11):1453-7. PubMed ID: 23273967
    [Abstract] [Full Text] [Related]

  • 17. Meningococcal conjugate vaccines: efficacy and new combinations.
    Sáfadi MA, Barros AP.
    J Pediatr (Rio J); 2006 Jul 01; 82(3 Suppl):S35-44. PubMed ID: 16826310
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C.
    Pediatr Infect Dis J; 2012 Jan 01; 31(1):e15-23. PubMed ID: 22094636
    [Abstract] [Full Text] [Related]

  • 20. Serogroup B meningococcal vaccines.
    Zimmer SM, Stephens DS.
    Curr Opin Investig Drugs; 2006 Aug 01; 7(8):733-9. PubMed ID: 16955685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.